• Team
    ▼
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    ▼
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Crowley Law, LLC

Crowley Law New Frontier

Call: 844-256-5891
  • Team
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers
  • Team
    • Philip P. Crowley
    • Christian Jensen
    • Jay S. Pattumudi
    • Anthony Wilkinson
    • David Kanarfogel
  • About
    • Technology
    • Life Sciences
  • Services
  • Resources
  • Contact Us
  • Careers

Implications of SCOTUS inter partes review ruling on biologics

5.19.18

One recent decision by the U.S. Supreme Court might have escaped the notice of many in the country. We doubt that entrepreneurs in New Jersey and elsewhere missed the news, however, considering the potential scope of the ruling across all areas of industry, including life sciences.

The case was Oil States Energy Services, LC, v Greene’s Energy Group, LLC. The issue was whether inter partes review (IPR), an administrative process instituted by the U.S. Patent and Trademark Office to deal with challenges to patents, violates the Constitutional guarantees due process in the courts against a taking by the government.

In a 7-2 ruling, the court said the IPR system is OK and went further by explaining that patents, rather than being property owned by holders, are public rights granted by the government. In that context, the justices said, the USPTO’s use of IPR is a legitimate exercise of its rights-granting authority.

While the decision specifically addressed questions related to patents covering devices and methods used in hydraulic fracturing for petroleum extraction, legal observers say the implications are far broader than that. Nearly all industries stand to be affected, including the fields of biologic and biosimilar pharmaceuticals. Analysts note that developers of biosimilar drugs regularly rely on IPR as a means to challenge the validity of patents granted for biologic drugs.

With the decision, biosimilar drug makers are assured of being able to continue using the IPR process, which offers the potential for faster and less costly adjudication of patent challenges than going through the courts.

The legal matters associated with any new or existing business endeavor create unique challenges. To anticipate and avoid issues, or deal with disputes when they arise, it’s important to work with an attorney who understands nuances of monetizing science and technology.

Primary Sidebar

Depend on us to keep you informed with our monthly newsletter and invites to informative webinars and seminars.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Crowley Law LLC, 89 Headquarters Plaza, Morristown, NJ, 07960, https://www.crowleylawllc.com/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Privacy Disclaimer

Footer

Crowley Law LLC
Business & Technology Attorneys


Phone: 844-256-5891
Email: [email protected]
New Jersey Office | New York Office
About | Services | Resources & Events | Contact Us

Awards Disclaimer

Copyright © 2023 by Crowley Law LLC.
All rights reserved. Terms of Use / Privacy Policy | Sitemap
Attorney Advertising. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Website by New Frontier

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Cookie settingsACCEPTREJECT Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT